Champions Oncology (CSBR) Misses Q3 EPS by 10c

March 12, 2024 5:36 PM EDT

Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.16), $0.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $12 million versus the consensus estimate of $13.5 million.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings